Invivyd IVVD
NASDAQ IVVD
$0.67 +0.03 (+4.52%)
As of: Oct 21, 2026 · 11:20 AM EDT

Invivyd (IVVD) EPS (Diluted) (2021 - 2026)

Updated

Invivyd (IVVD) recorded EPS (Diluted) of -$0.14 in Q2 2026, compared with -$0.12 a year earlier.

Analysis

Invivyd (IVVD) EPS (Diluted) (2021 - 2026) Analysis & Trends

On a TTM basis, Invivyd's EPS (Diluted) came in at -$0.25 as of Jun 30, 2026; for FY2025, it was -$0.30.

  • Across earlier years, EPS (Diluted) came in at -$1.43 in FY2024, -$1.81 in FY2023, -$2.23 in FY2022 and -$5.32 in FY2021.
  • The Q2 2026 figure is the lowest quarterly EPS (Diluted) since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,131.67 Bn 1,100.26 Bn 19.71 Bn 7.94
2 Johnson & Johnson 614.28 Bn 532.81 Bn 17.26 Bn 2.27
3 AbbVie 503.23 Bn 476.34 Bn 12.70 Bn 2.04
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn -0.54
5 Novartis Ag 298.22 Bn 262.21 Bn 11.24 Bn 1.67
6 Astrazeneca 261.55 Bn 235.23 Bn 12.86 Bn 1.60
7 Amgen 235.92 Bn 191.31 Bn 7.24 Bn 4.37
8 Gilead Sciences 190.78 Bn 164.98 Bn 6.22 Bn -8.44
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn -0.04
10 Invivyd 213.99 Mn -292.65 Mn 13.01 Mn -0.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.14
Dec 31, 2025 -0.06
Sep 30, 2025 -0.06
Jun 30, 2025 -0.12
Mar 31, 2025 -0.14
Dec 31, 2024 -0.16
Sep 30, 2024 -0.51
Jun 30, 2024 -0.40
Mar 31, 2024 -0.38
Dec 31, 2023 -0.67
Sep 30, 2023 -0.36
Jun 30, 2023 -0.46
Mar 31, 2023 -0.32
Dec 31, 2022 -0.41
Sep 30, 2022 -0.42
Jun 30, 2022 -0.47
Mar 31, 2022 -0.93
Dec 31, 2021 -1.95
Sep 30, 2021 -0.98
Jun 30, 2021 -178.86
API Access

Invivyd EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=IVVD&period=max&api_key=YOUR_API_KEY